# A Study of [14C]-LY3866288 in Healthy Participants

> **NCT06644378** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C]-LY3866288
- **DRUG:** LY3866288
- **DRUG:** [14C]-LY3866288

## Key facts

- **NCT ID:** NCT06644378
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-28
- **Primary completion:** 2025-01-03
- **Final completion:** 2025-01-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06644378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06644378, "A Study of [14C]-LY3866288 in Healthy Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06644378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*